ConductScience.org, home

Library / Genes

BSG: basigin (Ok blood group)

1 protein, 200 patents, 2 drugs, 1 trial, 2,700 NIH grants and 7,450 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolBSGHGNC
Namebasigin (Ok blood group)HGNC
NCBI Gene ID682NCBI Gene
HGNC IDHGNC:1116HGNC
EnsemblENSG00000172270NCBI Gene
Aliases5F7, CD147, EMMPRIN, EMPRIN, HAb18G, OK, TCSFNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P35613Basigin38518Ensembl, GeneID, HGNCUniProt

Patents 200

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4830787 A12026-10-281P35613Espacenet
WO 2026069561 A2026-04-021P35613Espacenet
JP 2026004568 A2026-01-1438632P35613Espacenet
JP 2026000906 A2026-01-0614P35613Espacenet
EP 4650780 A22025-11-196043P35613Espacenet
EP 4640849 A22025-10-29871P35613Espacenet
EP 4641201 A22025-10-295781P35613Espacenet
JP 2025147176 A2025-10-061580P35613Espacenet
JP 2025531671 A2025-09-2513P35613Espacenet
JP 2025529142 A2025-09-04604P35613Espacenet

Drugs 2

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
GAVILIMOMABCHEMBL2109193Basigin otherOTHERChEMBL
ZIRALIMUMABCHEMBL2108784Basigin inhibitorINHIBITORChEMBL

Trials 1

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT00035880GAVILIMOMABPHASE2/PHASE3ClinicalTrials.gov

NIH grants 2700

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant102,025NIH's project files
ZIAAI001020Host Immune Responses to Antigens of Malaria Parasites102,025NIH's project files
P30CA016672Cancer Center Support Grant82,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award82,025NIH's project files
P30CA013148Comprehensive Cancer Center Support Grant62,025NIH's project files
P30CA046934University of Colorado Cancer Center Support Grant62,025NIH's project files
P30AI045008Penn Center for AIDS Research52,025NIH's project files
P30CA054174Mays Cancer Center at UT Health SA52,025NIH's project files
P30CA068485Cancer Center Support Grant52,025NIH's project files
ZIAAI000241Malaria Parasite Ligands And Host Cell Receptors52,025NIH's project files

Papers 7450

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42782420PubTator, text miningPubMed
42773474PubTator, text miningPubMed
42739747PubTator, text miningPubMed
42723078PubTator, text miningPubMed
42719797PubTator, text miningPubMed
42714160PubTator, text miningPubMed
42710246PubTator, text miningPubMed
42682883PubTator, text miningPubMed
42652122PubTator, text miningPubMed
42634348PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license